相关实验视频
Updated: Jan 13, 2026

Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
信号分子和认知障碍的诊断:当前状态和前景
Igor Kvetnoy1,2, Oleg Kheyfets3,4, Lazar Safaniev5
1Medical Institute, Saint-Petersburg State University, 199034 Saint-Petersburg, Russia.
识别分子生物标志物对于诊断像阿尔茨海默氏症这样的认知障碍至关重要.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 医学诊断 医学诊断 医学诊断
背景情况:
- 认知障碍带来了重大挑战,原因是患病率高,缺乏有效的治疗方法.
- 早期识别分子生物标志物对于理解和管理神经退行性疾病至关重要.
- 目前的诊断方法需要改进,以准确地描述认知障碍的生物学特征.
研究的目的:
- 审查用于诊断认知障碍的相关信号分子.
- 在临床实践中评估综合分子生物标记面板的有效性.
- 分析阿尔茨海默病 (AD) 和血管痴呆症 (VD) 患者的生物标志物表达.
主要方法:
- 关于信号分子的文献综述.
- 生物标记面板的分析包括β-粉样蛋白,CD34,克劳丁,DRP1,内甲蛋白-1,NF-kB,PINK1,RAGE,S100,α-synuclein和tau蛋白.
- 在AD和VD患者中对生物标志物表达的比较分析.
主要成果:
- 信号分子表达的累积变化与神经退行和血管过程相关.
- 特定的生物标志物显示出区分认知障碍的潜力.
- 该研究确定了与AD和VD相关的关键分子特征.
结论:
- 综合性的分子生物标志物面板为诊断认知障碍提供了前景.
- 在临床应用这些生物标志物之前,需要进一步验证.
- 基于生物标志物的诊断可能会导致更个性化的认知障碍治疗策略.
更多相关视频
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
相关概念视频
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Types of Signaling Molecules
Language and Cognition
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitivism
Previously dominated by behaviorism, which prioritized observable behaviors and largely ignored mental processes, psychology transformed in the 1950s. Cognitive psychologists argue that understanding how we think and process...
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...